Lucy Coassin is a Director at Northpond Ventures and CEO of Hawthorne Health. She has held roles at Current Health, Science 37, Farcast Biosciences, Genentech, and Life Technologies.
At firms with a similar stage, sector and check size.




One email when Lucy's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckLucy Coassin is a Director at Northpond Ventures and CEO of Hawthorne Health. She has held roles at Current Health, Science 37, Farcast Biosciences, Genentech, and Life Technologies.
Lucy Coassin invests through Northpond Ventures, which writes checks of $1M to $3M at seed, series a.
Email [email protected], the firm's inbox for founders, and name Lucy in the subject. A warm intro from a founder Northpond Ventures backed works better.
business development and commercial roles at Life Technologies; business development and commercial roles at Genentech; business development and commercial roles at Farcast Biosciences; business development and commercial roles at Science 37; Head of Pharma at Current Health; Chief Executive Officer, Interim at Hawthorne Health.
Last updated 2026-10-15. Is this you? Ask for a correction.